Doses to the right coronary artery and the left anterior descending coronary artery and death from ischemic heart disease after breast cancer radiotherapy: a case-control study in a population-based cohort
DOI:
https://doi.org/10.2340/1651-226X.2024.19677Keywords:
breast cancer, cardiotoxicity, coronary arteries, late side-effects, cancer survivorshipAbstract
Background and purpose: Doses to the coronary arteries in breast cancer (BC) radiotherapy (RT) have been suggested to be a risk predictor of long-term cardiac toxicity after BC treatment. We investigated the dose–risk relationships between near maximum doses (Dmax) to the right coronary artery (RCA) and left anterior descending coronary artery (LAD) and ischemic heart disease (IHD) mortality after BC RT.
Patients and methods: In a cohort of 2,813 women diagnosed with BC between 1958 and 1992 with a follow-up of at least 10 years, we identified 134 cases of death due to IHD 10–19 years after BC diagnosis. For each case, one control was selected within the cohort matched for age at diagnosis. 3D-volume and 3D-dose reconstructions were obtained from individual RT charts. We estimated the Dmax to the RCA and the LAD and the mean heart dose (MHD). We performed conditional logistic regression analysis comparing piecewise spline transformation and simple linear modeling for best fit.
Results: There was a linear dose–risk relationship for both the Dmax to the RCA (odds ratio [OR]/Gray [Gy] 1.03 [1.01–1.05]) and the LAD (OR/Gy 1.04 [1.02–1.06]) in a multivariable model. For MHD there was a linear dose–risk relationship (1,14 OR/Gy [1.08–1.19]. For all relationships, simple linear modelling was superior to spline transformations.
Interpretation: Doses to both the RCA and LAD are independent risk predictors of long-term cardiotoxicity after RT for BC In addition to the LAD, the RCA should be regarded as an organ at risk in RT planning.
Downloads
References
Preston DL, Shimizu Y, Pierce DA, et al. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003 Oct;160(4):381–407.
https://doi.org/10.1667/RR3049 DOI: https://doi.org/10.1667/RR3049
McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011 Aug;100(2):167–75.
https://doi.org/10.1016/j.radonc.2011.06.016 DOI: https://doi.org/10.1016/j.radonc.2011.06.016
Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994 Mar;12(3):447–53.
https://doi.org/10.1200/JCO.1994.12.3.447 DOI: https://doi.org/10.1200/JCO.1994.12.3.447
Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557–65.
https://doi.org/10.1016/S1470-2045(05)70251-5 DOI: https://doi.org/10.1016/S1470-2045(05)70251-5
Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013 Mar 14;368(11):987–98.
https://doi.org/10.1056/NEJMoa1209825 DOI: https://doi.org/10.1056/NEJMoa1209825
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005 Dec 17;366(9503):2087–106.
https://doi.org/10.1016/S0140-6736(05)67887-7 DOI: https://doi.org/10.1016/S0140-6736(05)67887-7
Killander F, Wieslander E, Karlsson P, et al. No increased cardiac mortality or morbidity of radiation therapy in breast cancer patients after breast-conserving surgery: 20-year follow-up of the randomized SweBCGRT trial. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):701–9.
https://doi.org/10.1016/j.ijrobp.2020.04.003 DOI: https://doi.org/10.1016/j.ijrobp.2020.04.003
Milo MLH, Thorsen LBJ, Johnsen SP, et al. Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: a population-based Danish Breast Cancer Group study. Radiother Oncol. 2021 Apr;157:106–13.
https://doi.org/10.1016/j.radonc.2021.01.010 DOI: https://doi.org/10.1016/j.radonc.2021.01.010
Taylor CW, Wang Z, Macaulay E, et al. Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):845–53.
https://doi.org/10.1016/j.ijrobp.2015.07.2292 DOI: https://doi.org/10.1016/j.ijrobp.2015.07.2292
Bhattacharya S, Asaithamby A. Ionizing radiation and heart risks. Semin Cell Dev Biol. 2016 Oct;58:14–25.
https://doi.org/10.1016/j.semcdb.2016.01.045 DOI: https://doi.org/10.1016/j.semcdb.2016.01.045
Nilsson G, Holmberg L, Garmo H, et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012 Feb 1;30(4):380–6.
https://doi.org/10.1200/JCO.2011.34.5900 DOI: https://doi.org/10.1200/JCO.2011.34.5900
Jacob S, Camilleri J, Derreumaux S, et al. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study). Radiat Oncol. 2019 Feb 7;14(1):29.
https://doi.org/10.1186/s13014-019-1234-z DOI: https://doi.org/10.1186/s13014-019-1234-z
Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007 Mar 7;99(5):365–75.
https://doi.org/10.1093/jnci/djk064 DOI: https://doi.org/10.1093/jnci/djk064
Sioka C, Exarchopoulos T, Tasiou I, et al. Myocardial perfusion imaging with (99 m)Tc-tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study. Radiat Oncol. 2011 Nov 8;6:151.
https://doi.org/10.1186/1748-717X-6-151 DOI: https://doi.org/10.1186/1748-717X-6-151
Taylor C, McGale P, Brønnum D, et al. Cardiac structure injury after radiotherapy for breast cancer: cross-sectional study with individual patient data. J Clin Oncol. 2018 Aug 1;36(22):2288–96.
https://doi.org/10.1200/JCO.2017.77.6351 DOI: https://doi.org/10.1200/JCO.2017.77.6351
Moignier A, Broggio D, Derreumaux S, et al. Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation. Radiother Oncol. 2015 Dec;117(3):467–72.
https://doi.org/10.1016/j.radonc.2015.07.043 DOI: https://doi.org/10.1016/j.radonc.2015.07.043
Wennstig AK, Wadsten C, Garmo H, et al. Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort. Breast Cancer Res. 2020 Jan 22;22(1):10.
https://doi.org/10.1186/s13058-020-1249-2 DOI: https://doi.org/10.1186/s13058-020-1249-2
Durrleman S, Simon R. Flexible regression models with cubic splines. Statist Med. 1989;8(5):551–61.
https://doi.org/10.1002/sim.4780080504 DOI: https://doi.org/10.1002/sim.4780080504
Taylor CW, Nisbet A, McGale P, et al. Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother Oncol. 2009 Jan;90(1):127–35.
https://doi.org/10.1016/j.radonc.2008.09.029 DOI: https://doi.org/10.1016/j.radonc.2008.09.029
Taylor CW, Povall JM, McGale P, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):501–7.
https://doi.org/10.1016/j.ijrobp.2007.12.058 DOI: https://doi.org/10.1016/j.ijrobp.2007.12.058
Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s–1990s. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1484–95.
https://doi.org/10.1016/j.ijrobp.2007.05.034 DOI: https://doi.org/10.1016/j.ijrobp.2007.05.034
Duane F, Aznar MC, Bartlett F, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017 Mar;122(3):416–22.
https://doi.org/10.1016/j.radonc.2017.01.008 DOI: https://doi.org/10.1016/j.radonc.2017.01.008
van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017 Apr 10;35(11):1171–8.
https://doi.org/10.1200/JCO.2016.69.8480 DOI: https://doi.org/10.1200/JCO.2016.69.8480
Wilhelmsen L, Johansson S, Ulvenstam G, et al. CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg. Int J Epidemiol. 1989;18(3 Suppl 1):S101–8.
https://doi.org/10.1093/ije/18.3_Supplement_1.S101 DOI: https://doi.org/10.1093/ije/18.3_Supplement_1.S101
Wilhelmsen L, Rosengren A, Johansson S, et al. Coronary heart disease attack rate, incidence and mortality 1975–1994 in Goteborg, Sweden. Eur Heart J. 1997 Apr;18(4):572–81.
https://doi.org/10.1093/oxfordjournals.eurheartj.a015299 DOI: https://doi.org/10.1093/oxfordjournals.eurheartj.a015299
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Mats Perman, Karl-Axel Johansson, Erik Holmberg, Per Karlsson
This work is licensed under a Creative Commons Attribution 4.0 International License.
